Topical clindamycin is a first-line treatment for a severe type of acne that happens when bacteria clog pores and triggers the immune system to respond and cause inflammation (inflammatory acne).

Prevention is the first line of defense when it comes to ... When that does inevitably happen, we like to reach for a spot treatment. What causes acne? In the pursuit of glowy skin, I've come ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more I used to suffer from really bad acne, but I was able to get it under control with a regimen of hard ...

Therapeutic systems contain multiple products that all work together to help reduce blemishes and heal your skin.

This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne - - ...

Each patient should receive education regarding acne and the available treatment options. A realistic explanation of the benefits, risks and expected outcomes of each therapy must be provided to ...

Uncover how hormones, diet, and habits fuel chin acne and learn effective strategies to achieve clear, healthier skin for ...

The experts further explain: "Tretinoin, under the brand name Retin-A, was the first retinoid" used as treatment for acne during the 70s. But the benefits didn't stop there with research showing ...

It is the only FDA-approved laser for treating mild to severe acne. “Aviclear is one of the newest revolutionary treatments for ... “We were one of the first practices in the country to ...

This is Dermata's first issued U.S. patent for XYNGARI, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI clini ...

"Given the unique features and benefits of DMT310, we believe, if approved, it could potentially transform the current acne treatment guidelines and allow DMT310 to be a first-line treatment option.